STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
The moves bring stability to an agency that's been rocked by the exits of top leadership.
Read at STAT News · 8 September 2026 at 21:15
STAT+: FDA names acting heads of drug and vaccine centers to permanent roles
All coverage of this event, automatically grouped from multiple independent sources.
Last updated: 8 September 2026 at 23:19 · 7 articles · 1 sources
STAT+: FDA warns an API supplier about residue on walls, a corroded product line, and open-toed sandals
The FDA warned a supplier of active pharma ingredients about residue on walls, a corroded product line, and open-toed sandals at its facility. It also included photos.
Read at STAT News · 8 September 2026 at 17:38
STAT+: UnitedHealth’s Democrat investment, and surprise billing bloat debate
UnitedHealth execs shower a top Democrats with cash, and the No Surprises Act debate heats up.
Read at STAT News · 8 September 2026 at 14:51
STAT+: Health care features prominently in Democrats’ agenda
Democrats are sharpening their health care plans as the midterm elections near.
Read at STAT News · 8 September 2026 at 14:22
STAT+: Oura files to goes public, reported $1.2B in earnings
In health tech news today, Oura reports a profit, the FDA loses another key digital health leader, and more
Read at STAT News · 8 September 2026 at 14:18
STAT+: FDA approves AstraZeneca breast cancer drug
Roivant drug delivers mid-stage results, Moonwalk raises funds to develop longer-lasting obesity drugs, and more biotech news
Read at STAT News · 8 September 2026 at 14:09
STAT+: Pharmalittle: We’re reading about another Novartis trial failure, a Novo Nordisk setback, and more
An experimental Novartis drug for a rare neuromuscular condition failed to improve muscle function in a pivotal study
Read at STAT News · 8 September 2026 at 13:26